A Model of the return and risk of various new drug development projects using Research Backed Obligations
碩士 === 國立政治大學 === 財務管理研究所 === 104 === Biomedical innovation has become riskier and more difficult to finance with traditional sources such as private and public equity. Here we propose a financial structure called RBO (Research Backed Obligations) which is similar to Mortgage Backed Securities. In R...
Main Author: | 陳朕疆 |
---|---|
Other Authors: | 陳明吉 |
Format: | Others |
Language: | zh-TW |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/11788045172135166390 |
Similar Items
-
以研究支持債券(Research Backed Obligation, RBO)為各類新藥研發計劃募資的風險與報酬
by: 陳朕疆 -
To Return or Not to Return? IRB Perspectives on Obligations to Return Genetic Incidental Findings to Research Participants
by: Yurkiewicz, Ilana
Published: (2015) -
Research of civil obligations-Focus on the loyalty and confidentiality obligations
by: Hsiu-Yueh Yang, et al.
Published: (2011) -
The research of obligations on partnership
by: Chi-cheng Wu, et al. -
Returning the Favor? Feeling Obliged and Reported Participation in Discretionary Safety Activities
by: Julie Laurent, et al.
Published: (2021-08-01)